Chapter 27 – Water, Electrolytes & Acid-Base (Fluids) 01

Overview

  • Focus: Maintenance of body-fluid homeostasis (water, electrolytes, acid–base) – BIOL 2314 • Chapter 27 • Module 1 (Fluids)
  • Key variables continually regulated
    • Total body-water (TBW)
    • Distribution between intracellular fluid (ICF) & extracellular fluid (ECF)
    • ECF subdivisions: plasma, interstitial fluid, plus minor components (lymph, cerebro-spinal fluid, synovial fluid, etc.)
    • Osmolality (≈ solute concentration, expressed in mOsmkg1\text{mOsm}\,\text{kg}^{-1})
    • Blood pressure/volume
    • Electrolyte composition (especially Na+\text{Na}^+, Cl\text{Cl}^-, K+\text{K}^+)
    • Acid–base balance (covered in later modules)

Body-Fluid Compartments

  • Percent of body mass occupied by water varies with age, sex & adiposity (adipose tissue contains comparatively little water).
  • Table 27.1 – Typical percentage distribution
    • Infants
    • TBW ≈ 75%75\%
    • ICF ≈ 45%45\%
    • ECF ≈ 30%30\%
      • Plasma ≈ 4%4\%
      • Interstitial fluid ≈ 26%26\%
    • Adult males
    • TBW ≈ 60%60\%
    • ICF ≈ 40%40\%
    • ECF ≈ 20%20\%
      • Plasma ≈ 5%5\%
      • Interstitial fluid ≈ 15%15\%
    • Adult females
    • TBW ≈ 50%50\% (greater adipose proportion)
    • ICF ≈ 35%35\%
    • ECF ≈ 15%15\%
      • Plasma ≈ 5%5\%
      • Interstitial fluid ≈ 10%10\%
    • Minor ECF components (<<1 % each): lymph, cerebrospinal fluid (CSF), aqueous/vitreous humors, synovial fluid, serous fluids, etc.

Water Balance – Intake vs. Loss

  • Normal daily turnover: 15003000mL day11500{-}3000\,\text{mL day}^{-1} (≈ ±\pm a full kidney/plasma volume every 24 h!)
  • Intake sources
    • Ingested liquids & foods ≈ 90%90\% (driven largely by thirst)
    • Metabolic water ≈ 10%10\% (product of aerobic catabolism; major during starvation/desert adaptation)
  • Loss routes
    • Sensible (measurable)
    • Urine ≈ 61%61\% of total, primary route for volume & solute regulation
    • Feces ≈ 4%4\% (variable with diet/diarrhea)
    • Insensible (non-perceptible evaporation)
    • Evaporation ≈ 35%35\%
      • Diffusion/evaporation across skin (no sweat glands involved)
      • Respiratory water loss (humidification of inspired air)
    • Perspiration (active sweat)
      • Electrolyte content: Na+\text{Na}^+, Cl\text{Cl}^-, K+\text{K}^+, urea, ammonia
      • In hot environments: additional 100150mL100{-}150\,\text{mL} for every 1C1^{\circ}\text{C} rise in core/ambient temperature

Fluid Movement – Hydrostatic vs. Osmotic Forces (Fig. 27.3)

  • Starling forces govern exchange between plasma & interstitial compartments
    • Hydrostatic pressure (filtration) – pushes water out of blood at arterial end
    • Colloid osmotic pressure (re-absorption) – pulls water into blood at venous end (primarily due to plasma proteins)
  • Scenarios
    • (b) Equal osmotic pressure → no net fluid shift; cells unchanged
    • (c) High interstitial osmolality → water exits capillary; cells may shrink (dehydration)
    • (d) High plasma osmolality → water enters capillary; cells may swell (over-hydration)

Variations in Body-Fluid Volume

  • Dehydration (negative water balance)
    • Causes: prolonged diarrhea, excessive sweating, vomiting, inadequate intake
    • Early S/Sx: dizziness, dry mouth, headache, lethargy, muscle weakness
    • Severe S/Sx: delirium, dry skin, fever, sunken eyes, ↓ tissue turgor, ↑ blood viscosity
    • ↑ viscosity → ↓ BP, compensatory ↑ HR; can progress to circulatory collapse/heart failure
  • Edema (positive interstitial balance)
    • Definition: Interstitial fluid volume exceeds plasma volume
    • Mechanisms
    1. Inflammation → ↑ capillary permeability to proteins → proteins leak into interstitium → local osmotic gradient pulls water out (exudate)
    2. Venous obstruction / heart failure → ↑ venous hydrostatic pressure → filtration > re-absorption; lymphatic return overwhelmed, fluid accumulates

Regulation Mechanisms

  • The body uses overlapping negative-feedback loops to keep
    1. ECF osmolality constant (primarily via water handling)
    2. ECF volume/BP constant (primarily via Na+\text{Na}^+ handling)

1. Antidiuretic Hormone (ADH / Vasopressin)

  • Sensors
    • Hypothalamic osmoreceptors (sense ↑ plasma osmolality ≥ ≈ 1%1\%)
    • Arterial & atrial baroreceptors (sense ↓ BP/BV)
  • Integration: Hypothalamus → posterior pituitary releases ADH
  • Effectors
    • Kidneys: ↑ water reabsorption by making distal convoluted tubule (DCT) & collecting ducts water-permeable (insertion of aquaporin-2)
    • Arterioles: mild vasoconstriction (↑ total peripheral resistance)
  • Outcomes (Fig. 27.9/27.10)
    • ↑ BV, ↑ BP; ↓ plasma osmolality + quenched thirst → HOMEOSTASIS RESTORED
  • Decreased osmolality produces reverse sequence → ↓ ADH → diuresis

2. Atrial Natriuretic Hormone (ANH / ANP)

  • Trigger: Stretch of right atrial wall (↑ venous return/↑ BP)
  • Endocrine source: Atrial myocytes release ANH into bloodstream (Fig. 27.8)
  • Renal actions
    • ↑ GFR (dilates afferent, constricts efferent arteriole)
    • Inhibits Na+\text{Na}^+ & water reabsorption in collecting duct
    • Inhibits renin, aldosterone, and ADH secretion
  • Net effect: ↑ urine volume (natriuresis + diuresis) → ↓ BV & BP

3. Renin–Angiotensin–Aldosterone System (RAAS)

  • Trigger: ↓ renal perfusion pressure or sympathetic stimulation → juxtaglomerular apparatus releases renin (Fig. 27.7)
  • Sequence
    Renin+AngiotensinogenAngiotensin I\text{Renin} + \text{Angiotensinogen} \rightarrow \text{Angiotensin I}
    ACE (lungs):Ang IAngiotensin II\text{ACE (lungs)}: \text{Ang I} \rightarrow \text{Angiotensin II}
  • Angiotensin II actions
    • Potent vasoconstrictor → rapid ↑ BP
    • Stimulates adrenal cortex (zona glomerulosa) → ↑ aldosterone
  • Aldosterone actions
    • Na+\text{Na}^+ reabsorption (and thus water) & K+\text{K}^+ secretion in distal nephron
    • Net: ↓ urine volume, ↑ BV & BP

Hierarchy / Interactions

  • ADH primarily corrects osmolality; RAAS & ANH primarily correct volume/pressure, but all interrelate (e.g., Aldosterone indirectly affects osmolality long-term by changing Na+\text{Na}^+ content; ADH affects volume acutely).

Thirst Mechanism (Fig. 27.5)

  • Stimuli for thirst perception (hypothalamic thirst center)
    1. ↑ ECF osmolality (hypertonicity) sensed by osmoreceptors
    2. ↓ BP/BV sensed by baroreceptors (and by RAAS via Ang II acting centrally)
  • Behavioral effector: Water ingestion (slow; ~30 min to absorb)
  • Negative feedback: Ingested water ↓ osmolality & ↑ BV → stretch & sensory feedback to hypothalamus → thirst subsides

Clinical & Practical Notes

  • Elderly & infants are at higher risk for dehydration/over-hydration → immature or blunted thirst & hormonal responses.
  • Certain pathologies
    • Diabetes insipidus: ADH deficiency or renal insensitivity → massive dilute diuresis, hypernatremia
    • SIADH (syndrome of inappropriate ADH): excessive ADH → water retention, hyponatremia, cerebral edema
    • Congestive heart failure: ↓ effective circulatory volume → chronic RAAS activation → edema (despite total BV excess) – rationale for ACE inhibitors & diuretics.
  • Environmental/occupational medicine: Heat stroke risk ↑ with high insensible losses; need electrolyte-containing fluids to replace sweat solutes.

Key Numbers & Relationships (quick-reference)

  • Normal plasma osmolality: 275295mOsmkg1\approx 275{-}295\,\text{mOsm}\,\text{kg}^{-1}
  • Daily water turnover: 1.53.0L1.5{-}3.0\,\text{L}
  • Starling equilibrium (simplified):
    Net filtration=(P<em>cP</em>i)(π<em>cπ</em>i)\text{Net filtration} = (P<em>c - P</em>i) - (\pi<em>c - \pi</em>i)
    where PP = hydrostatic pressures, π\pi = oncotic pressures, subscripts c = capillary, i = interstitium.
  • Sweat electrolyte composition (≈ mmol L1^{-1})
    • Na+\text{Na}^+ ≈ 40-60, Cl\text{Cl}^- ≈ 40-60, K+\text{K}^+ ≈ 4-8, urea ≈ 5-10, ammonia ≈ 1-2.

Concept Integration / Real-World Relevance

  • Homeostatic loops are classic negative feedback systems – foundational concept linking physiology & control theory.
  • Pharmacology tie-ins
    • ACE inhibitors, ARBs blunt RAAS → treat hypertension & heart failure
    • V2 receptor antagonists (vaptans) counteract SIADH
    • Diuretics exploit nephron segment physiology to manipulate water & Na+^+ handling.
  • Ethical/practical: Safe fluid therapy requires understanding these mechanisms (e.g., avoiding rapid correction of chronic hyponatremia to prevent osmotic demyelination).